This paper examines the pathophysiological mechanisms underlying two major hyperglycemic crises — diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic non-ketotic syndrome (HHNS/HHS) — and irritable bowel syndrome (IBS). The paper explains how insulin deficiency drives ketone body accumulation, hyperglycemia, and dehydration in DKA, then contrasts these processes with the more severe dehydration but milder ketosis seen in HHS. It further outlines three proposed pathophysiology models for IBS: alterations in gut microbiota, gut-brain axis dysfunction affecting motility, and psychological stress activating neuroendocrine pathways. Together, these discussions illustrate how disruptions in metabolic and gastrointestinal homeostasis produce distinct but sometimes overlapping clinical presentations.
The paper employs comparative pathophysiology — a technique in which two related but distinct conditions (DKA and HHS) are analyzed side by side to identify mechanistic similarities and differences. This approach strengthens clinical reasoning by showing how shared precipitating factors (insulin deficiency) can lead to divergent outcomes depending on the degree of residual beta-cell function.
The paper is organized as two question-and-answer units. The first unit addresses DKA across two paragraphs — one focused on ketogenesis and one on the counter-regulatory hormone cascade — before transitioning to HHS for comparison. The second unit addresses IBS through three distinct pathophysiology models: gut microbiota changes, gut motility and the gut-brain axis, and psychological stress. Each model is clearly introduced and supported by citations, making the structure easy to follow.
Diabetic ketoacidosis (DKA) is a diabetes-related complication that disproportionately affects patients with Type 1 diabetes (Elendu et al., 2023). It is characterized by an absolute or relative deficiency in insulin and a surge in hormones that trigger insulin resistance — such as catecholamines, growth hormone, and glucagon — leading to electrolyte imbalance, ketosis, dehydration, and hyperglycemia (Elendu et al., 2023). The precipitating event of DKA is often insulin deficiency resulting from infections, improper insulin administration, or missed doses, which inhibits the intracellular transportation of glucose (Elendu et al., 2023). This triggers intracellular starvation and hunger, as cells lack sufficient glucose for energy generation.
As a result, cells begin to use free fatty acids (FFA) to generate energy. The low levels of insulin limit effective adipocyte lipolysis, leading to increased concentrations of FFA in the bloodstream. These FFA are then transported to the mitochondria in the liver for oxidation, leading to the formation of ketone bodies (Elendu et al., 2023). Because insulin levels are insufficient to effectively regulate biochemical processes, ketone bodies are produced in excessive amounts, overwhelming the body and leading to ketosis (Elendu et al., 2023).
In a second pathophysiology model, insulin deficiency may trigger the release of cortisol, catecholamines, glucagon, and growth hormone. These counter-regulatory hormones lead to accelerated glycogenolysis and increased gluconeogenesis, both of which increase hepatic glucose production and decrease tissue uptake, triggering hyperglycemia (Elendu et al., 2023). If not accompanied by adequate fluid intake, hyperglycemia leads to electrolyte loss, hyperosmolarity, dehydration, and reduced glomerular filtration (i.e., reduced renal function). Reduced renal function worsens hyperosmolarity, diminishes intracellular potassium utilization, and causes significant potassium depletion (Elendu et al., 2023), which is why DKA patients typically present with low serum potassium concentrations.
The pathophysiology of hyperosmolar hyperglycemic syndrome (HHS) is similar to that of DKA, with only mild differences. As with DKA, HHS is precipitated by insulin deficiency that decreases intracellular glucose utilization, leading to hyperglycemia (Ortowska et al., 2024). Hyperglycemia triggers hyperosmolarity and increases the osmotic gradient, causing free water to be drawn out of the intracellular space and excreted via the urinary tract, resulting in dehydration that is often more severe than that caused by DKA (Ortowska et al., 2024). The risk of cardiovascular failure is also higher in HHS due to this severe dehydration (Ortowska et al., 2024).
Unlike DKA, however, HHS is characterized by reduced production of ketone bodies and, consequently, a lower risk of ketosis (Ortowska et al., 2024). This is because in HHS, beta cells in the pancreas continue to produce insulin, which inhibits ketogenesis. Thus, compared to DKA, HHS is associated with lower glucagon levels and higher insulin levels, leading to mild — if any — ketosis. HHS is therefore typically indicated by the absence of ketoacidosis, an osmolarity exceeding 320 mOsm/L, and blood glucose levels above 600 mg/dL (Ortowska et al., 2024).
Always verify citation format against your institution’s current style guide requirements.